Atlas Trials

Concurrent Chemo-radiotherapy With Capecitabine for Unresectable Locally Advanced Pancreatic Carcinoma

Clinical trial NCT00658840 · UNKNOWN

Trial details

NCT number
NCT00658840
Sponsor
National Cancer Center, Korea
Status
UNKNOWN
Phase
Phase 2
Study type
INTERVENTIONAL
Pancreatic Cancer
Start date
2006-06-01
Primary completion
2013-06-01
Enrollment
55

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.